Abstract:Rationale: Giant cell arteritis (GCA)a primary vasculitis of medium and large arteriesis associated with vessel wall damage, elastic membrane fragmentation, and vascular remodeling. Proteinases are believed to contribute to pathogenesis by degrading extracellular matrix and causing tissue injury. Objective: The MMP (matrix metalloproteinase)-9a type IV collagenaseis produced in the vasculitic lesions of GCA. It is unknown which pathogenic processes are MMP-9 dependent. Methods and Results: The tissue transcriptome of GCA-affected temporal arteries contained high amounts of MMP-9 transcripts, and immunostaining for pro-MMP-9 localized the enzyme to wall-infiltrating macrophages. MMP-2 and MMP-9 transcripts were also abundant in monocytes and monocyte-derived macrophages from patients with GCA. Patient-derived monocytes outperformed healthy monocytes in passing through engineered basement membranes. GCA CD (cluster of differentiation) 4(+) T cells required MMP-9-producing monocytes to penetrate through matrix built from type IV collagen. In vivo functions of MMP-9 were tested in a human artery-SCID (severe combined immunodeficiency) chimera model by blocking enzyme activity with a highly specific monoclonal antibody or by injecting rMMP-9 (recombinant MMP-9). Inhibiting MMP-9 activity profoundly suppressed vascular injury, decreased the density of inflammatory infiltrates (P<0.001), reduced intramural neoangiogenesis (P<0.001), and prevented intimal layer hyperplasia (P<0.001). rMMP-9 amplified all domains of vasculitic activity, promoted assembly of T-cell infiltrates (P<0.05), intensified formation of new microvessels (P<0.001), and worsened intimal thickening (P<0.001). Systemic delivery of N-acetyl-proline-glycine-prolinea matrikine produced by MMP-9-mediated gelatinolysishad limited vasculitogenic effects. Conclusions: In large vessel vasculitis, MMP-9 controls the access of monocytes and T cells to the vascular wall. T cells depend on MMP-9-producing monocytes to pass through collagen IV-containing basement membrane. Invasion of vasculitogenic T cells and monocytes, formation of neoangiogenic networks, and neointimal growth all require the enzymatic activity of MMP-9, identifying this protease as a potential therapeutic target to restore the immunoprivilege of the arterial wall in large vessel vasculitis.

Deficiency of the CD155-CD96 Immune Checkpoint Controls IL-9 Production in Giant Cell Arteritis

Immunoinhibitory Checkpoint Deficiency in Medium and Large Vessel Vasculitis

Immune Checkpoint Dysfunction in Large and Medium Vessel Vasculitis.

Pro-inflammatory and Anti-Inflammatory T Cells in Giant Cell Arteritis

Single-cell transcriptomic profiling reveals a pathogenic role of cytotoxic CD4+ T cells in giant cell arteritis

Decoding CD4 + T cell transcriptome in giant cell arteritis: Novel pathways and altered cross-talk with monocytes

MMP (matrix Metalloprotease)-9–Producing Monocytes Enable T Cells to Invade the Vessel Wall and Cause Vasculitis

Inhibition of JAK-STAT Signaling Suppresses Pathogenic Immune Responses in Medium and Large Vessel Vasculitis

Impaired IL-6-induced JAK-STAT signaling in CD4 + T cells associates with longer treatment duration in giant cell arteritis

Vasculitogenic T Cells in Large Vessel Vasculitis

Cytokines, Growth Factors and Proteases in Medium and Large Vessel Vasculitis.

Cytotoxic CX3CR1+ T cells drive vascular inflammation in giant cell arteritis but not in Takayasu's arteritis

Pathogenesis of giant-cell arteritis: how targeted therapies are influencing our understanding of the mechanisms involved

NOTCH-induced rerouting of endosomal trafficking disables regulatory T cells in vasculitis

Circulating PD-1hi CXCR5- and CXCR5+ CD4 T cells are elevated in patients with newly diagnosed Giant Cell Arteritis and predict relapse

Predominance of T-bet-positive Th1 cells in infiltrating T-lymphocytes in most of active arteritis lesions of giant cell arteritis

Giant Cell Arteritis: Advances in Understanding Pathogenesis and Implications for Clinical Practice

CD28 Signaling Controls Metabolic Fitness of Pathogenic T Cells in Medium and Large Vessel Vasculitis

Senescent cells in giant cell arteritis display an inflammatory phenotype participating in tissue injury via IL-6-dependent pathways

Current Insights into Tissue Injury of Giant Cell Arteritis: From Acute Inflammatory Responses towards Inappropriate Tissue Remodeling

The IL-17 pathway as a target in giant cell arteritis